{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:21:09Z","timestamp":1787764869571,"version":"build-2784847793"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Sputnik V vaccine was approved in India in April 2021 to tackle the pandemic situation. However, there was lack of information on the effects, side effects, and peoples' perception toward it. The present case study aims to evaluate the vaccine coverage, the awareness, and perception toward it and compare the adverse effects after each dose.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS:<\/jats:title>\n                    <jats:p>A unique case study was conducted in a sample of 200 participants comparing 2 groups of population who took first and second dose of Sputnik V vaccine during June to November 2021. The data were collected by a prevalidated questionnaire, follow-up telephonic interviews focused on knowledge, awareness, side effects of vaccine, and analyzed using descriptive statistics such as frequency, percentages, mean, and standard deviation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>The vaccine coverage for first and second doses were 98.3% and 96.5%, respectively. The mean age of the participant was 29 + 9.5 years and majority 68.5% were males. Seventeen percent experienced the S\/E for the vaccine with 9.5% from second dose. There were usual side effects; however, it was more after second dose of vaccination. Friends and healthcare workers were the main source of information (33.5%) and motivation (43%). Majority (73.5%) were aware of the side effects. Forty three point five percent took vaccine attributed to its protective role, availability, and peer pressure. There was no significant association between type of doses and side effects of the respective doses of vaccine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>The vaccine coverage was &gt;90%. Participants were well aware of the vaccine and side effects which were more in second dose. However, there was no significant difference between the two doses of vaccine.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jehp.jehp_322_23","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T06:14:23Z","timestamp":1698732863000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Sputnik V vaccine perception and hesitancy in a tertiary health care centre transformed to Covid-19 vaccine centre: A case study"],"prefix":"10.4103","volume":"12","author":[{"given":"A","family":"Priyadharshini","sequence":"first","affiliation":[{"name":"Community Medicine, Great Eastern Medical School and Hospital, Srikakulam, Andhra Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarina","family":"Begum","sequence":"additional","affiliation":[{"name":"Community Medicine, Manipal Tata Medical College, Manipal Academy of Higher Education, Jamshedpur, Jharkhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed I.","family":"Ali","sequence":"additional","affiliation":[{"name":"Community Medicine, Manipal Tata Medical College, Manipal Academy of Higher Education, Jamshedpur, Jharkhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyajit","family":"Pattnaik","sequence":"additional","affiliation":[{"name":"Community Medicine, Great Eastern Medical School and Hospital, Srikakulam, Andhra Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhananjaya","family":"Sharma","sequence":"additional","affiliation":[{"name":"Community Medicine, Great Eastern Medical School and Hospital, Srikakulam, Andhra Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D Lakshmi","family":"Lalitha","sequence":"additional","affiliation":[{"name":"Biochemistry, GEMS and Hospital, Srikakulam, Andhra Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,10]]},"reference":[{"issue":"3","key":"R1-20240829","doi-asserted-by":"crossref","first-page":"105924","DOI":"10.1016\/j.ijantimicag.2020.105924","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges","volume":"55","author":"Lai","year":"2020","journal-title":"International journal of antimicrobial agents"},{"issue":"3","key":"R2-20240829","first-page":"e7423","article-title":"Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update","volume":"12","author":"Pal","year":"2020","journal-title":"Cureus"},{"key":"R3-20240829","journal-title":"WHO Director-General's opening remarks at the media briefing on COVID19 -March 2020 [Google Scholar]"},{"key":"R4-20240829","doi-asserted-by":"crossref","DOI":"10.1111\/jocn.15290","article-title":"Life in the pandemic: social isolation and mental health","author":"Usher","year":"2020","journal-title":"J Clin Nurs"},{"key":"R5-20240829","article-title":"Weekly epidemiological update on COVID-19-31 August 2022 [Internet]","journal-title":"Who.int"},{"key":"R6-20240829","article-title":"India: WHO Coronavirus disease (COVID-19) dashboard with vaccination data [Internet]","journal-title":"Who.int"},{"key":"R7-20240829","article-title":"FAQs on COVID-19 Vaccines and Vaccination Program [Internet]","author":"General","journal-title":"Gov.in"},{"issue":"4","key":"R8-20240829","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3390\/idr14040057","article-title":"Mix-and-match COVID-19 vaccinations (heterologous boost): A review","volume":"14","author":"Garg","year":"2022","journal-title":"Infect Dis Rep [Internet]"},{"key":"R9-20240829","article-title":"Sputnik V vaccine-efficacy, doses, side effects and price [Internet]","year":"2021","journal-title":"Pacehospital.com"},{"key":"R10-20240829","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(21)00234-8","article-title":"Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: An interim analysis of a randomised controlled phase 3 trial in Russia","volume":"397","author":"Logunov","year":"2021","journal-title":"Lancet (London, England)"},{"key":"R11-20240829","first-page":"38","article-title":"ROCCA observational study: Early results on safety of Sputnik V vaccine (Gam-COVID-Vac) in the Republic of San Marino using active surveillance","volume":"2021","author":"Montalti","journal-title":"E Clinical Medicine"},{"issue":"1","key":"R12-20240829","doi-asserted-by":"crossref","first-page":"21464","DOI":"10.1038\/s41598-021-00963-7","article-title":"Side effects and Immunogenicity following administration of the Sputnik V COVID-19 vaccine in health care workers in Iran","volume":"11","author":"Babamahmoodi","year":"2021","journal-title":"Scientific reports"},{"issue":"3","key":"R13-20240829","first-page":"408","article-title":"Active monitoring of early safety of Sputnik V vaccine in Buenos Aires, Argentina. Monitoreo activo de la seguridad temprana de la vacunaci\u00f3n con Sputnik V en Buenos Aires, Argentina","volume":"81","author":"Pagotto","year":"2021","journal-title":"Medicina"},{"issue":"Pt B","key":"R14-20240829","doi-asserted-by":"crossref","first-page":"108351","DOI":"10.1016\/j.intimp.2021.108351","article-title":"Prevalence of COVID-19 vaccines (Sputnik V, AZD-1222, and Covaxin) side effects among healthcare workers in Birjand city, Iran","volume":"101","author":"Zare","year":"2021","journal-title":"International immunopharmacology"},{"key":"R15-20240829","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1002\/jmv.27655","article-title":"Adverse events following immunization of COVID-19 (Covaxin) vaccine at a tertiary care center of India","volume":"94","author":"Parida","year":"2022","journal-title":"J Med Virol"},{"issue":"Suppl 2","key":"R16-20240829","doi-asserted-by":"crossref","first-page":"S283","DOI":"10.1016\/j.mjafi.2021.06.014","article-title":"Adverse events following ChAdOx1 nCoV-19 Vaccine (COVISHIELD) amongst health care workers: A prospective observational study","volume":"77","author":"Kamal","year":"2021","journal-title":"Med J Armed Forces India"},{"key":"R17-20240829","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"key":"R18-20240829","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"R19-20240829","doi-asserted-by":"crossref","first-page":"e0261869","DOI":"10.1371\/journal.pone.0261869","article-title":"A model of factors influencing COVID-19 vaccine acceptance: A synthesis of the theory of reasoned action, conspiracy theory belief, awareness, perceived usefulness, and perceived ease of use","volume":"17","author":"Akther","year":"2022","journal-title":"PLoS One [Internet]"},{"key":"R20-20240829","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/s41591-021-01454-y","article-title":"COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries","volume":"27","author":"Sol\u00eds Arce","year":"2021","journal-title":"Nat Med"}],"container-title":["Journal of Education and Health Promotion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jehp.jehp_322_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:48:53Z","timestamp":1787762933000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jehp.jehp_322_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jehp.jehp_322_23","relation":{},"ISSN":["2277-9531","2319-6440"],"issn-type":[{"value":"2277-9531","type":"print"},{"value":"2319-6440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"2023-03-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}